Organization Overview
Historical Acquisition Tree
Alternative names
Key: Millennium Pharmaceuticals (2) Acquired (1)
alemtuzumab (campath) (2001 NDA)
bortezomib (velcade) (2003 NDA)
ixazomib (ninlaro) (2015)
autologous mononuclear stem cell (4 trials)
azacitidine (vidaza) (11 trials)
bexarotene (targretin) (1 trial)
bicalutamide (casodex) (1 trial)
bleomycin (blenoxane) (4 trials)
carboplatin (paraplatin) (11 trials)
cytarabine (cytosar-u) (11 trials)
dacarbazine (dtic-dome) (5 trials)
doxorubicin (Doxil) (28 trials)
etoposide (vepesid) (12 trials)
gemcitabine (gemzar) (6 trials)
Key: Millennium Pharmaceuticals (66) Acquired (1)
alemtuzumab (campath) (2 trials)
allogeneic bone marrow (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
allogeneic stem cells (1 trial)
autologous hematopoietic stem cells (2 trials)
bendamustine (treanda) (5 trials)
bevacizumab (avastin) (3 trials)
cyclosporine (sandimmune) (1 trial)
degarelix acetate (firmagon) (1 trial)
docetaxel (taxotere) (10 trials)
exemestane (aromasin) (1 trial)
Filgrastim (neupogen) (1 trial)
fludarabine (fludara) (5 trials)
fulvestrant (faslodex) (2 trials)
hemopoietic stem cell (2 trials)
irinotecan (Camptosar) (4 trials)
itraconazole (sporanox) (4 trials)
leuprolide (lupron) (3 trials)
metoclopramide (reglan) (2 trials)
mitoxantrone (novantrone) (5 trials)
paclitaxel (taxol) (13 trials)
panitumumab (vectibix) (1 trial)
panobinostat (farydak) (1 trial)
pegaspargase (oncaspar) (1 trial)
pentostatin (nipent) (1 trial)
peripheral blood lymphocytes (1 trial)
plerixafor (mozobil) (1 trial)
relugolix (ORGOVYX) (3 trials)
sodium fluoride (18F) (1 trial)
sorafenib (nexavar) (3 trials)
atorvastatin (lipitor) (1 trial)
cholera vaccine (Vaxchora) (1 trial)
clarithromycin (biaxin) (1 trial)
daunorubicin (cerubidine) (1 trial)
esomeprazole (nexium) (3 trials)
fluconazole (diflucan) (2 trials)
hepatitis b vaccine (recombinant) (Recombivax) (1 trial)
ibrutinib (imbruvica) (1 trial)
ketoconazole (nizoral) (2 trials)
lansoprazole (prevacid) (1 trial)
mercaptopurine (purinethol) (1 trial)
Acute Disease (Phase 3)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 2)
Adenocarcinoma, Mucinous (Phase 1)
Amyloidosis (Phase 3)
Apnea (Phase 1)
Astrocytoma (Phase 1)
Atherosclerosis (Phase 2)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Basal Cell (Phase 1)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 1)
Cardiovascular Diseases (Phase 2)
Central Nervous System Neoplasms (Phase 2)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 3)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 2)
Complex Regional Pain Syndromes (Phase 2)
Critical Illness (Phase 2)
Crohn Disease (Phase 4)
Cystadenocarcinoma (Phase 1)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Treatment-Resistant (Phase 2)
Diabetes Mellitus (Phase 1)
Digestive System Neoplasms (Phase 1)
Disease (Phase 2)
Disease Progression (Phase 3)
Disorders of Excessive Somnolence (Phase 1)
Endometrial Neoplasms (Phase 2)
Endometriosis (Phase 1)
Enteropathy-Associated T-Cell Lymphoma (Phase 1)
Ependymoma (Phase 1)
Epstein-Barr Virus Infections (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fistula (Phase 4)
Frailty (Phase 2)
Gastrointestinal Neoplasms (Phase 1)
Gastroparesis (Phase 2)
Genital Neoplasms, Female (Phase 1)
Genital Neoplasms, Male (Phase 1)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Graft vs Host Disease (Phase 3)
Head and Neck Neoplasms (Phase 1)
Hodgkin Disease (Phase 4)
Idiopathic Hypersomnia (Phase 1)
Immunoblastic Lymphadenopathy (Phase 1)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Inflammatory Bowel Diseases (Phase 1)
Leukemia (Phase 3)
Leukemia, Large Granular Lymphocytic (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 1)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Leukemia, Myelomonocytic, Juvenile (Phase 3)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Leukemia, T-Cell (Phase 1)
Lip Neoplasms (Phase 1)
Liver Diseases (Phase 1)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 1)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 1)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Cutaneous (Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 3)
Lymphoproliferative Disorders (Phase 2)
Melanoma (Phase 1)
Mesothelioma (Phase 2)
Metaplasia (Phase 1)
Monosomy (Phase 2)
Multiple Myeloma (Phase 4)
Multiple Sclerosis (Phase 2)
Mycoses (Phase 3)
Mycosis Fungoides (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Neoplasms (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Plasma Cell (Phase 4)
Nervous System Neoplasms (Phase 2)
Neuroblastoma (Phase 1)
Oligodendroglioma (Phase 1)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Papilloma (Phase 1)
Peritoneal Neoplasms (Phase 2)
Philadelphia Chromosome (Phase 3)
Plasmablastic Lymphoma (Phase 2)
Plasmacytoma (Phase 3)
Polycythemia (Phase 1)
Preleukemia (Phase 3)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Rectal Fistula (Phase 3)
Rectal Neoplasms (Phase 1)
Recurrence (Phase 2)
Reflex Sympathetic Dystrophy (Phase 2)
Renal Insufficiency (Phase 1)
Rhabdoid Tumor (Phase 2)
Schizophrenia (Phase 2)
Sclerosis (Phase 2)
Sezary Syndrome (Phase 2)
Sleep Apnea, Obstructive (Phase 1)
Sleep Apnea Syndromes (Phase 1)
Sleepiness (Phase 1)
Small Cell Lung Carcinoma (Phase 2)
Smoldering Multiple Myeloma (Phase 2)
Somatoform Disorders (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Syndrome (Phase 3)
Teratoma (Phase 2)
Thoracic Neoplasms (Phase 1)
Thrombocytopenia (Phase 2)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 1)
Ulcer (Phase 3)
Urethral Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 2)
Urogenital Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 2)
Vaginal Neoplasms (Phase 2)
Virus Diseases (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)